Irish medtech company HealthBeacon, which was recently granted FDA clearance allowing it to enter the US market, has opened its newly expanded headquarters in Dublin.
The company, founded in 2013, has developed a technology platform known as the Smart Sharps System, which helps patients adhere to their medication schedule with digital reminders.
The company was a finalist in the 2017 Irish Times Innovation Awards. Its backers include Oyster Capital and Elkstone Partners.
The company, which has doubled staff numbers over the past 18 months to 30 people, has offices in Ireland, Canada and the US.
HealthBeacon announced plans late last year to raise an additional €5 million last year to bring total funds to more than €8 million.
"2018 has been a fast track year for HealthBeacon and today reflects our successes and our ongoing continued investment here in Ireland, our global headquarters," said chief executive Jim Joyce.
